Cited by 40Telomeres, Telomerase, and SenescenceCancer-related Molecular PathwaysGenetics, Aging, and Longevity in Model Organisms

Telomere shortening and cell fates in mouse models of neoplasia

Artandi, Steven E·2002·Trends in Molecular Medicine

Abstract

Cell division in the absence of telomerase leads to telomere shortening that can activate checkpoint responses and impair chromosomal stability. The absence of telomerase in primary human cells and its near universal reactivation in human cancers has highlighted the importance of telomere shortening and telomerase reactivation during tumor development. Data from telomerase-deficient mouse models of cancer have indicated that telomere shortening can exert profoundly different influences on cell fates in developing cancers, limiting tumorigenesis by enhancing cell death or facilitating carcinogenesis by compromising chromosomal stability. These alternate fates depend on the integrity of the p53 pathway and on cell type.

Integrity signals

Registry

Crossref · 10.1016/s1471-4914(01)02222-5

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic cellular damage leading to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer.

    “Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”

    From Telomeres and telomerase in cancer (2010) · cites this paper as [134]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Artandi, S. E.
Affiliations
Stanford Medicine (US)
Corresponding author
Artandi, Steven E
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2002-01
Volume
8
Issue
1
Pages
44-47
ISSN
1471-4914 (ISSN-L)
OpenAlex
W2077247569
Cited by
40
References
13
Citations by year
2024: 1 · 2022: 1 · 2021: 5 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2014: 2 · 2012: 3
FWCI
0.41
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
telomere shortening, telomerase, cell fate, carcinogenesis, chromosome stability, p53 pathway, cell death, cell division
MeSH terms
Animals, Cell Division, Disease Models, Animal, Humans, Models, Biological, Neoplasms, Genes, p53, Telomere, Cell Death, Apoptosis, Cell Lineage, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review